Mylan Labs

Report: Mylan may have overcharged US by $1.3B for EpiPen
Report: Mylan may have overcharged US by $1.3B for EpiPen
Drug Delivery Business News
Mylan Labs
EpiPens
Medicaid
Flag link:
Sunovion slammed by FDA rejection of nebulized LAMA for COPD as rival lines up a competing NDA
Sunovion slammed by FDA rejection of nebulized LAMA for COPD as rival lines up a competing NDA
Endpoints
Sunovion
FDA
LAMA
COPD
Theravance
Mylan Labs
Flag link:
The top 15 generic drugmakers by 2016 revenue
The top 15 generic drugmakers by 2016 revenue
Fierce Pharma
generics
Teva Pharmaceutical
Mylan Labs
Novartis
Pfizer
Allergan
Flag link:
Fresh off an M&A spree, Mylan may need another buy to keep growing: analyst
Fresh off an M&A spree, Mylan may need another buy to keep growing: analyst
Fierce Pharma
Mylan Labs
M&A
earnings
Flag link:
Mylan (MYL) Tops on Q1 Earnings
Mylan (MYL) Tops on Q1 Earnings
NASDAQ.com
Mylan Labs
earnings
Flag link:
Mylan's Coury caps a year of controversy with $97M exit-pay package
Mylan's Coury caps a year of controversy with $97M exit-pay package
Fierce Pharma
Mylan Labs
executive pay
Robert Coury
Flag link:
Sanofi Sues Mylan Over EpiPen Practices
Sanofi Sues Mylan Over EpiPen Practices
TheStreet.com
Sanofi
Mylan Labs
EpiPens
Flag link:
As a competitor encroached, Mylan took one state to court to push EpiPen sales, documents show
As a competitor encroached, Mylan took one state to court to push EpiPen sales, documents show
Stat
Mylan Labs
EpiPens
Medicaid
Flag link:
Meet the lawyer trying to pry drug pricing secrets out of Big Pharma
Meet the lawyer trying to pry drug pricing secrets out of Big Pharma
Stat
Big Pharma
drug pricing
Mylan Labs
EpiPen
insulin
Eli Lilly
Novo Nordisk
Sanofi
Flag link:
FDA jumps on another Mylan plant in India, slapping it with a warning letter
FDA jumps on another Mylan plant in India, slapping it with a warning letter
Fierce Pharma
FDA
drug manufacturing
India
Mylan Labs
Flag link:
About that pharma M&A comeback? Sorry. 2017's not bringing it—at least not yet
About that pharma M&A comeback? Sorry. 2017's not bringing it—at least not yet
Fierce Pharma
M&A
Stada
Shire
Baxalta
JNJ
Actelion
Mylan Labs
Pfizer
Takeda
Ariad Pharmaceuticals
Medivation
Flag link:
GlaxoSmithKline Dodges a Bullet... for Now
GlaxoSmithKline Dodges a Bullet... for Now
Motley Fool
GSK
generics
Advair
asthma
Mylan Labs
Flag link:
EpiPen purchasers level class action against Mylan over price hikes
EpiPen purchasers level class action against Mylan over price hikes
Mass Device
Mylan Labs
EpiPens
drug pricing
Class Action Lawsuit
Flag link:
Mylan stock slumps 1.3% after company says voluntary recall will include U.S. EpiPens
Mylan stock slumps 1.3% after company says voluntary recall will include U.S. EpiPens
Marketwatch
Mylan Labs
recalls
EpiPens
Flag link:
Mylan shutters Meda plant, cuts 90 jobs
Mylan shutters Meda plant, cuts 90 jobs
BioPharma Dive
Mylan Labs
Meda
drug manufacturing
layoffs
Flag link:
How Much Pain Will Congress Inflict on These Opioid Drugmakers' Stocks?
How Much Pain Will Congress Inflict on These Opioid Drugmakers' Stocks?
Motley Fool
congress
opioids
Mylan Labs
Purdue Pharma
Insys
Depomed
JNJ
Flag link:
GSK breathes sigh of relief as Mylan Advair copy rejected
GSK breathes sigh of relief as Mylan Advair copy rejected
BioPharma Dive
GSK
Advair
generics
Mylan Labs
Flag link:
Mylan stock sinks 2% after FDA fails to approve its generic asthma medication
Mylan stock sinks 2% after FDA fails to approve its generic asthma medication
Marketwatch
Mylan Labs
FDA
generics
asthma
GSK
Advair Diskus
Flag link:
Senators launch investigation into opioid manufacturers
Senators launch investigation into opioid manufacturers
BioPharma Dive
Senate
opioids
Purdue Pharma
JNJ
Insys
Mylan Labs
Depomed
Flag link:
Abbott divests 60% of its stake in Mylan
Abbott divests 60% of its stake in Mylan
Mass Device
Abbott Labs
Mylan Labs
generics
Flag link:

Pages